Smithers Rapra are excited to confirm that Bristol-Myers Squibb and Eli Lilly will be speaking at this year's much-anticipated Extractables & Leachables Europe, taking place in Lyon this November.
|Kathryn McGohan, Scientist I at Bristol-Myers Squibb, will be presenting on Implementation of BPOG Best Practices Guide for Leachables: Leachables Study Design as part of the Biocompatibility session on Thurs 9 November.
|Frances Sexton, TS/MS Bioprocess Chemist - Materials Management at Eli Lilly, will be presenting on Extractables & Leachables - Where Does the Risk Really Lie as part of Regulatory Landscape, Expectations & Protocol Insights session on Weds 8 November.
This year's programme promises to be one of the best yet, with traditional topics including the regulatory landscape and best practice combined with brand new topics including sessions dedicated to food contact and medical devices.
Leading companies including AbbVie, Baxter, GlaxoSmithKline, Becton Dickinson, Smithers Rapra, Clariant and more will be providing their insights, latest results and case studies, AND this is also the first time that both the MHRA and the FDA will be presenting opening keynotes, so this is truly an event not to miss.
Click here to view the full programme >
Click here to download the full attendee list >
Click here to book your ticket >